These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27440273)

  • 1. Sustained Mutant KIT Activation in the Golgi Complex Is Mediated by PKC-θ in Gastrointestinal Stromal Tumors.
    Kim WK; Yun S; Park CK; Bauer S; Kim J; Lee MG; Kim H
    Clin Cancer Res; 2017 Feb; 23(3):845-856. PubMed ID: 27440273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics of KIT and protein kinase C-δ expression in adenoid cystic carcinoma: comparison with chromophobe renal cell carcinoma and gastrointestinal stromal tumour.
    Park CK; Kim WK; Kim H
    Histopathology; 2017 Oct; 71(4):529-542. PubMed ID: 28561935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic signaling by Kit tyrosine kinase occurs selectively on the Golgi apparatus in gastrointestinal stromal tumors.
    Obata Y; Horikawa K; Takahashi T; Akieda Y; Tsujimoto M; Fletcher JA; Esumi H; Nishida T; Abe R
    Oncogene; 2017 Jun; 36(26):3661-3672. PubMed ID: 28192400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
    Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
    Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias.
    Blay P; Astudillo A; Buesa JM; Campo E; Abad M; García-García J; Miquel R; Marco V; Sierra M; Losa R; Lacave A; Braña A; Balbín M; Freije JM
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4089-95. PubMed ID: 15217944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors.
    Motegi A; Sakurai S; Nakayama H; Sano T; Oyama T; Nakajima T
    Pathol Int; 2005 Mar; 55(3):106-12. PubMed ID: 15743318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.
    Jang BG; Lee HE; Kim WH
    Virchows Arch; 2015 Oct; 467(4):393-403. PubMed ID: 26243012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological characteristics and prognostic criteria for gastrointestinal stromal tumors].
    Tsyganova IV; Anurova OA; Mazurenko NN
    Arkh Patol; 2011; 73(6):37-42. PubMed ID: 22379899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
    J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOG1 and PKC-θ are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors.
    Kang GH; Srivastava A; Kim YE; Park HJ; Park CK; Sohn TS; Kim S; Kang DY; Kim KM
    Mod Pathol; 2011 Jun; 24(6):866-75. PubMed ID: 21358619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
    Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
    Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.
    Kim KH; Nelson SD; Kim DH; Choi KU; Kim SJ; Min KW; Jang KS; Paik SS; Oh YH; Chae SW; Sohn JH; Kim HJ; Cho YK; Kim BI; Park DI; Sohn CI; Oh S; Choi SH; Choi YJ; Woo HY; Park YL; Park SJ; Lee SH; Ryu S; DO SI; Kang G; Kim K; Cho YH; Pyo JS
    Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors.
    Tabone-Eglinger S; Subra F; El Sayadi H; Alberti L; Tabone E; Michot JP; Théou-Anton N; Lemoine A; Blay JY; Emile JF
    Clin Cancer Res; 2008 Apr; 14(8):2285-94. PubMed ID: 18413817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
    Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
    Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis.
    Quattrone A; Dewaele B; Wozniak A; Bauters M; Vanspauwen V; Floris G; Schöffski P; Chibon F; Coindre JM; Sciot R; Debiec-Rychter M
    J Pathol; 2012 Dec; 228(4):565-74. PubMed ID: 22786615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
    Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
    Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.
    Yun S; Kim WK; Kwon Y; Jang M; Bauer S; Kim H
    Int J Cancer; 2018 May; 142(10):2080-2093. PubMed ID: 29277888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors.
    Lai S; Wang G; Cao X; Luo X; Wang G; Xia X; Hu J; Wang J
    Oncotarget; 2016 Jan; 7(2):1367-79. PubMed ID: 26587973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Kit signalling on the Golgi is suppressed by blocking secretory trafficking with M-COPA in gastrointestinal stromal tumours.
    Obata Y; Horikawa K; Shiina I; Takahashi T; Murata T; Tasaki Y; Suzuki K; Yonekura K; Esumi H; Nishida T; Abe R
    Cancer Lett; 2018 Feb; 415():1-10. PubMed ID: 29196126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
    Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
    J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.